LB&I Directives provide administrative guidance to LB&I examiners to ensure consistent tax administration and on matters relating to internal operations. The Directives do not establish Service position on legal issues and are not legal guidance. LB&I (formerly LMSB) Directives 2020 Date Title 09-10-2020 Guidance for Allowance of the Credit for Increasing Research Activities Under I.R.C. Section 41 for Taxpayers That Expense Research and Development Costs on Their Financial Statements Pursuant to ASC 730 2019 Date Title 10-10-19 LB&I and SB/SE Joint Directive on the Work Opportunity Tax Credit per Internal Revenue Code Section 51 (IRC § 51) 2018 Date Title 11-29-18 LB&I Directive on Amended Return/Claim for Refund Relating to Internal Revenue Code Section 199 (IRC § 199) 08-24-18 IRC Section 807: LB&I Directive Related to Principle Based Reserves for Variable Annuity Contracts (AG 43/VM-21) and Life Insurance Contracts VM-20) 2017 Date Title 09-11-17 Activities under I.R.C §41 for Taxpayers that Expense Research and Development Costs on their Financial Statements pursuant to ASC 730 2015 Date Title 03-16-15 LB&I Directive on the I.R.C. § 199 Definition of "Manufactured, Produced, Grown, or Extracted" 2014 Date Title 10-24-14 LB&I Directive Related to § 166 Deductions for Eligible Debt and Eligible Debt Securities 10-14-14 Allocating Mixed Service Costs Under I.R.C. Section 263A to Certain Self-Constructed Property of Electric and Natural Gas Utilities 07-17-14 I.R.C. §446: LB&I Directive for Hedging of Variable Annuity Guaranteed Minimum Benefits (GMxB) by Insurance Companies 2013 Date Title 10-29-13 Updated Guidance for Examiners on I.R.C. § 199 Benefits and Burdens of Ownership Analysis in Contract Manufacturing Arrangements 2012 Date Title 12-07-12 Guidance for Computing and Substantiating the Credit for Increasing Research Activities under Section 41 of the Internal Revenue Code for Activities involved in Developing New Pharmaceutical Drugs and Therapeutic Biologics 07-30-12 I.R.C. §166: LB&I Directive Related to Partial Worthlessness Deduction for Eligible Securities Reported by Insurance Companies 01-23-12 Wireless Telecommunication Assets 2011 Date Title 04-14-11 I.R.C. §475: Field Directive related to Mark-to-Market Valuation Frequently Asked Questions for I.R.C. § 475 2006 Date Title 07-31-06 Industry Director Directive on Deductibility of Casino Complimentary Goods and Services 03-16-06 Industry Director Directive on Treatment of Semiconductor Assembly and Test Activities as Manufacturing 01-12-2006 Examination of Multiple Parties in Intermediary Transaction Tax Shelters as described in Notice 2001-16 2005 Date Title 08-26-05 Industry Director Directive Amended Returns/Refund Claims Containing Invalid IRC § 280(C)(3) Elections 03-04-05 Field Guidance on the Planning and Examination of the Cyclical Overhauls, Betterments, and Rebuilds of Locomotives for Class I Railroads 03-04-05 Field Guidance on the Planning and Examination of the Cyclical Overhauls, Betterments, and Rebuilds of Freight Cars for Class I Railroads 2004 Date Title 04-30-04 Planning and Examination of Research Credit Issues in a Branded Pharmaceutical Company Pharmaceutical Industry Research Credit Audit Guidelines Exhibit B - Hypothetical Organizational ChartPDF Exhibit C - Departmental Reporting Structure (Research Career Ladder)PDF Exhibit D - Research Credit Wage Issue Chart 04-16-04 Timber Casualty Losses Exhibit B - Issue Paper on Timber Casualty Losses - Valuation of a Single Identifiable Property 2003 Date Title 10-17-03 Examination of Legally Mandated Research and Experimentation Expenses in the Biotech and Pharmaceutical Industries 2002 Date Title 02-25-02 Audit Procedures for Golf Course Land Improvements - Change in Accounting Method 02-07-02 Depreciable Golf Course Land Improvements and the Impact of Rev. Rul. 2001-60 2001 Date Title 12-12-01 Conformity Election for Bank Bad Debts
